U.S. Health Care REITs Stock News

If you are wondering whether WeRide at around US$8.10 is a bargain or a value trap, the starting point is to understand what the current price implies about the business. The stock has moved 2.5% over the last 7 days and 27.6% over the last 30 days, although the return so far this year sits at a 13.7% decline and the 1 year return is a 7.8% decline. Recent coverage has focused on WeRide's position within autonomous driving and auto technology, as investors weigh how its products fit into...

If you are wondering whether G-III Apparel Group at around US$31.90 is offering good value today, the key is to compare the recent share performance with what the fundamentals might justify. The stock has posted returns of 8.3% over the last 7 days, 19.7% over 30 days, 8.1% year to date and 30.0% over 1 year, with a 3 year return of 110.6% and a 5 year return of 3.8%. Recent coverage has focused on how fashion brands are positioning themselves with wholesalers and retailers. It has also...

If you are wondering whether Nicolet Bankshares at around US$154.86 still offers value or if most of the upside is already priced in, the recent share performance gives you a useful starting point. The stock has returned 10.9% over the last 30 days, 28.5% year to date, 36.7% over 1 year and 181.8% over 3 years. This makes the current price action important context for any valuation work. Recent coverage has focused on how regional banks are being assessed on capital strength, loan quality...

If you are wondering whether Royalty Pharma's current share price still makes sense after a strong run, the key is to look closely at what the market might be pricing in. The stock last closed at US$49.48, with returns of 1.4% over 7 days, 9.1% over 30 days, 27.3% year to date and 57.4% over the past year, which naturally raises questions about how expectations and risk perceptions are being reflected in the price. Recent attention around Royalty Pharma has largely centered on its role as a...

Sonic Automotive has acquired five additional Harley-Davidson dealerships across the US, expanding its presence in the motorcycle retail market. Harley-Davidson has introduced a new global brand platform called "RIDE", including a refreshed visual identity and a large-scale marketing campaign. For investors watching NYSE:HOG, these developments come as the stock trades at $24.27, with a 38.1% return over the past 30 days and 17.6% year to date. Over a longer horizon, a 30.1% decline over...

FTAI Aviation (NasdaqGS:FTAI) has launched FTAI Power, a new platform focused on repurposing retired jet engines for AI data centers. The company also announced a second structured aircraft acquisition program, expanding its approach to sourcing and financing aircraft assets. These moves signal a wider set of opportunities for FTAI Aviation beyond traditional aviation leasing and engine services. FTAI Aviation operates in aircraft leasing and engine management, and now it is stepping...

Wondering if FirstCash Holdings at around US$208 a share still offers value, or if most of the upside is already priced in. The stock has returned 2.6% over the last week, 8.3% over the past month, 32.7% year to date and 73.0% over the last year, with 3 year and 5 year returns of 125.1% and 207.7% respectively. Recent coverage has focused on FirstCash Holdings' role in consumer finance and how its pawn and retail operations fit into broader credit conditions. This helps frame expectations...

AMC Robotics (AMCI) has just wrapped up FY 2025 with Q4 revenue of US$1.3 million and a basic EPS loss of US$0.52, while trailing twelve month figures show revenue of US$6.0 million and a basic EPS loss of US$1.36 alongside a reported 41.4% revenue decline over the year. Over the past few reported periods, quarterly revenue has ranged from US$1.3 million to US$3.2 million and basic EPS has swung between a profit of US$0.15 and a loss of US$0.52, underscoring how volatile the earnings line has...

IDEAYA Biosciences (NasdaqGS:IDYA) has entered a clinical collaboration with AstraZeneca to study IDE849, a DLL3 TOP1 antibody drug conjugate. The program will evaluate IDE849 in combination with Imfinzi in extensive stage small cell lung cancer and other DLL3 upregulated tumors. For readers tracking IDEAYA mainly through its uveal melanoma drug darovasertib, this collaboration with AstraZeneca broadens the story. The company, trading at $31.83, has delivered a 70.9% return over the past...

If you are wondering whether Calix at around US$49.58 still offers value or is starting to look stretched, the key is to look closely at what you are paying for each dollar of its future potential. The share price performance is mixed, with a 1.6% gain over the last 7 days, a 1.5% decline over 30 days, a 7.5% decline year to date, and a 31.8% return over the past year. These shifts can change how the market views both risk and opportunity. Investors have been reacting to ongoing industry...

JBT Marel (NYSE:JBTM) is bringing its Wenger and Extru-Tech brands together for the first time at Petfood Forum 2026. The combined presence will highlight solutions for minimally processed, nutrient-dense pet food manufacturing. The move showcases new equipment offerings and closer alignment across JBT Marel’s pet food processing portfolio. For investors tracking NYSE:JBTM, this joint showcase comes with the shares at $132.63 and a 1 year return of 40.4%. The stock has also recorded a 30.8%...

Columbia Financial (CLBK) opened 2026 with Q1 revenue of US$66.2 million and basic EPS of US$0.13, anchored by net income of US$13.1 million. This puts fresh numbers behind the company’s recent return to profitability. The business has seen revenue move from US$55.9 million and EPS of US$0.09 in Q1 2025 to US$66.2 million and EPS of US$0.13 in Q1 2026, with trailing twelve month EPS at US$0.55 as the earnings base rebuilds. With a Q1 net interest margin of 2.42% and a cost to income ratio of...

CoastalSouth Bancshares (COSO) opened 2026 with Q1 total revenue of US$21.3 million and basic EPS of US$0.53, supported by net income of US$6.3 million. Over recent quarters, total revenue has moved from US$18.0 million in Q1 2025 to US$21.3 million in Q1 2026, while quarterly EPS has ranged from US$0.49 to US$0.60 across that period. This provides a clearer view of how the income statement is scaling. With a trailing net profit margin of 31.6% holding steady and a net interest margin of...

Republic Services (NYSE:RSG) has opened an upgraded Peabody Recycling Center in Massachusetts. The facility features advanced AI powered technology aimed at improving recycling efficiency and processing capacity. The revamped site supports regional waste reduction efforts and reflects the company’s focus on technology driven operations. For investors tracking NYSE:RSG, this move fits squarely within Republic Services’ core role as a recycling and waste management operator. The company is...

Gogo Inc. ( NASDAQ:GOGO ), is not the largest company out there, but it received a lot of attention from a substantial...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Ocular Therapeutix (NasdaqGM:OCUL) released new 52-week post hoc Phase 3 data for AXPAXLI in wet age-related macular degeneration. The SOL-1 trial data indicated better durability, strong sustained disease control, and safety outcomes compared to aflibercept. The company presented the findings at a major ophthalmology conference and plans to seek FDA approval with a single pivotal Phase 3 trial. Ocular Therapeutix focuses on therapies for eye diseases, with AXPAXLI (OTX TKI) aimed at...

Agree Realty (NYSE:ADC) has approved increases to both its common and preferred dividends following board authorization. The updated payouts represent a change in the company’s dividend policy that is material for existing and prospective shareholders. These actions follow a period in which the stock has returned 10.3% year to date and 38.7% over 5 years, with the latest close at $79.56. For investors watching dividend income, Agree Realty’s new board-approved increases to both common and...

Last week, First Watch Restaurant Group, Inc.'s (NASDAQ:FWRG) stock jumped 16%, but insiders who sold US$4.6m worth of...

While Corsair Gaming, Inc. ( NASDAQ:CRSR ) might not have the largest market cap around , it led the NASDAQGS gainers...

Wondering whether QXO at around US$24.22 is offering value or asking too much of future expectations? This breakdown is designed to help you weigh that up calmly and clearly. The stock has shown sharp moves recently, with returns of 9.1% over 7 days, 29.9% over 30 days, 22.8% year to date, 90.4% over 1 year, 18.4% over 3 years, and a 38.4% decline over 5 years. These mixed returns give important context for thinking about what investors are currently pricing in and how sentiment toward QXO...

Zimmer Biomet Holdings (NYSE:ZBH) supported the nation’s first complete robotic assisted shoulder replacement in an ambulatory surgery center. The company appointed Dr. Jonathan M. Vigdorchik as Chief Science, Technology, and Medical Affairs Officer to oversee AI, robotics, and smart implant efforts. Zimmer Biomet enters this news cycle with shares at $95.48 and mixed long term returns. The stock is up 8.7% over the past 30 days and 6.1% year to date, while the 3 year and 5 year returns...

Steele Bancorp (OTCPK:STLE) has just posted Q1 2026 results with Q4 2025 numbers showing total revenue of US$13.5 million and basic EPS of US$1.64, capping off a trailing twelve month period where reported earnings grew 410.8%. Over the last year, total revenue has moved from US$4.59 million in Q4 2024 to US$13.5 million in Q4 2025, while trailing EPS climbed from US$2.41 to US$9.15, with much of that uplift tied to a one off US$12.8 million gain and a net profit margin that now sits at...

Autoliv (NYSE:ALV) is expanding beyond traditional car airbags into motorcycle and wearable airbag safety products. The company has introduced its first motorcycle airbag and wearable airbag solutions, targeting riders and other vulnerable road users. Autoliv has recently outperformed in Asian markets such as China, India, and South Korea alongside this product expansion. Autoliv, trading around $121.36, is increasingly tied to broader mobility safety rather than just passenger vehicles...